Noji Takehiro, Tanaka Kimitaka, Matsui Aya, Nakanishi Yoshitsugu, Asano Toshimichi, Nakamura Toru, Tsuchikawa Takahiro, Okamura Keisuke, Hirano Satoshi
Faculty of Medicine, Department of Gastroenterological Surgery II, Hokkaido University, Kita 15 Nishi 7, Kita-ku, Sapporo, Hokkaido, 060-8638, Japan.
J Gastrointest Surg. 2021 Sep;25(9):2358-2367. doi: 10.1007/s11605-020-04891-1. Epub 2021 Jan 5.
Previous studies have shown that curative resection (R0 resection) was among the most crucial factors for the long-term survival of patients with PHCC. To achieve R0 resection, we performed the transhepatic direct approach and resection on the limits of division of the hepatic ducts. Although a recent report showed that the resection margin (RM) status impacted PHCC patients' survival, it is still unclear whether RM is an important clinical factor.
To describe a technique of transhepatic direct approach and resection on the limit of division of hepatic ducts, investigate its short-term surgical outcome, and validate whether the radial margin (RM) would have a clinical impact on long-term survival of perihilar cholangiocarcinoma (PHCC) patients.
Consecutive PHCC patients (n = 211) who had undergone major hepatectomy with extrahepatic bile duct resection, without pancreaticoduodenectomy, in our department were retrospectively evaluated.
R0 resection rate was 92% and 86% for invasive cancer-free and both invasive cancer-free and high-grade dysplasia-free resection, respectively. Overall 5-year survival rate was 46.9%. Univariate analysis showed that preoperative serum carcinoembryonic antigen level (> 7.0 mg/dl), pathological lymph node metastasis, and portal vein invasion were independent risk factors, but R status on both resection margin and bile duct margin was not an independent risk factor for survival.
The transhepatic direct approach to the limits of division of the bile ducts leads to the highest R0 resection rate in the horizontal margin of PHCC. Further examination will be needed to determine the adjuvant therapy for PHCC to improve patient survival.
既往研究表明,根治性切除(R0切除)是影响肝门部胆管癌(PHCC)患者长期生存的关键因素之一。为实现R0切除,我们采用经肝直接入路并在肝管分支界限处进行切除。尽管最近有报告显示切缘(RM)状态会影响PHCC患者的生存,但RM是否为重要的临床因素仍不明确。
描述经肝直接入路并在肝管分支界限处进行切除的技术,研究其短期手术效果,并验证径向切缘(RM)是否会对肝门部胆管癌(PHCC)患者的长期生存产生临床影响。
回顾性评估我院连续收治的211例行肝外胆管切除的肝大部切除术、未行胰十二指肠切除术的PHCC患者。
无浸润癌切除及无浸润癌和高级别异型增生切除的R0切除率分别为92%和86%。总体5年生存率为46.9%。单因素分析显示,术前血清癌胚抗原水平(>7.0mg/dl)、病理淋巴结转移和门静脉侵犯是独立危险因素,但切缘和胆管切缘的R状态不是生存的独立危险因素。
经肝直接入路至胆管分支界限处可使PHCC水平切缘的R0切除率最高。需要进一步研究以确定PHCC的辅助治疗方案,从而提高患者生存率。